メニュー 戻るLS38 What Systems/Infrastructure Can Be Used for Pediatric Drug Development?

19th DIA Japan Annual Meeting 2022

New “Quest for the future”~Moving Creativity and Innovation Forward in “New Normal”~

価格は消費税抜きとなっております。

LS38 What Systems/Infrastructure Can Be Used for Pediatric Drug Development?

Session Chair(s)

Kayoko Kikuchi, PhD

Kayoko Kikuchi, PhD

  • Chief, Unit of Project Management, Clinical Research Center
  • National Center For Child Health and Development, Japan

Speaker(s)

Hidefumi Nakamura, MD, PhD

Hidefumi Nakamura, MD, PhD

  • Director for Clinical R&D,
  • National Center for Child Health and Development, Japan
Miyako Matsumizu, MPharm

Miyako Matsumizu, MPharm

  • Pfizer R&D Japan G.K., Japan
Seiko Bun

Seiko Bun

  • Ministry of Health, Labour and Welfare (MHLW), Japan
Kana Harada

Kana Harada

  • Child Life Specialist
  • Toho University Omori Medical Center, Japan